1. Home
  2. GSK vs CRH Comparison

GSK vs CRH Comparison

Compare GSK & CRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSK plc (Each representing two)

GSK

GSK plc (Each representing two)

N/A

Current Price

$55.51

Market Cap

96.1B

Sector

Health Care

ML Signal

N/A

Logo CRH PLC

CRH

CRH PLC

N/A

Current Price

$106.07

Market Cap

84.2B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GSK
CRH
Founded
1715
1936
Country
United Kingdom
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
96.1B
84.2B
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
GSK
CRH
Price
$55.51
$106.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
15
Target Price
N/A
$135.93
AVG Volume (30 Days)
5.3M
4.4M
Earning Date
01-01-0001
05-19-2026
Dividend Yield
3.22%
1.47%
EPS Growth
N/A
9.76
EPS
N/A
5.51
Revenue
N/A
$37,447,000,000.00
Revenue This Year
$6.81
$7.27
Revenue Next Year
$4.74
$5.24
P/E Ratio
$32.75
$19.21
Revenue Growth
N/A
5.27
52 Week Low
$32.38
$76.75
52 Week High
$61.70
$131.55

Technical Indicators

Market Signals
Indicator
GSK
CRH
Relative Strength Index (RSI) 45.67 26.68
Support Level $47.89 $88.97
Resistance Level $60.37 $114.18
Average True Range (ATR) 0.89 3.41
MACD -0.86 -1.81
Stochastic Oscillator 18.94 16.04

Price Performance

Historical Comparison
GSK
CRH

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About CRH CRH PLC

CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.

Share on Social Networks: